105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses
GSK will make most of its inhaled respiratory portfolio and other products available on a direct purchasing platform, offering savings of up to 66%
The pharma company will donate more than seven tons of its active pharmaceutical ingredient (API) to bolster the American supply chain
Enabling a new era in minimally invasive obesity treatment across Europe
The pharma giant's 11% rise in total revenue to $43.2 billion highlights consistent execution of its growth strategy
The new line features advanced isolator technology to deliver enhanced sterility assurance, throughput and operational precision
The US generic market is crucial for Indian pharma, contributing about 35% to its total revenue, around US$ 10.7 billion
The wP-IPV-based hexavalent vaccination is an innovative immunization alternative to the current pentavalent and standalone IPV vaccines
Report highlights significant improvements in adolescent well-being in India
Subscribe To Our Newsletter & Stay Updated
